A Real World Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to Standard of Care Basal Insulins in Insulin Naïve Patients Initiating Insulin
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 705 participants.
Also called NCT02967224
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 705 participants
- Sponsor
- Registry
-
NCT02967224 -
2015-001831-18
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Brazil, France, Germany, Ireland, Romania, Spain, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02967224. Randomized; no masking; primary purpose treatment. Start 2015-11-05 (registry gives no type); primary completion 2017-10-16 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating Insulin
- Acronym
- Reach-Control
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- insulin glargine (U300)
- Intervention (Drug)
- insulin glargine (U100)
- Intervention (Drug)
- NPH insulin
- Intervention (Drug)
- insulin detemir
- Intervention (Drug)
- insulin degludec
- Lead sponsor
- Sanofi
Record details
- Record id
cardio:ct-nct02967224- Content hash
6f663d16c527964ba54b3579a731be4427680f52f36920ecb70801fc3c070fd3